Condition: Recurrent Nasopharyngeal Carcinoma
Intervention: Drug: Nimotuzumab
Sponsors: Fujian Cancer Hospital; Sun Yat-sen University; Jiangxi Provincial Cancer Hospital; Zhejiang Cancer Hospital; Fujian Medical University Union Hospital
Recruiting
https://ift.tt/2x3xN1J
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου